Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Highly Accessed Research

Significance of ERβ expression in different molecular subtypes of breast cancer

Liying Guo1*, Jie Meng1, Dilimina Yilamu1, Adina Jakulin1, Minggang Fu1, Bowei Wang2 and Gulinaer Abulajiang2

Author Affiliations

1 Department of Breast, Digestive & Vascular Center, First Affiliated Hospital of Xinjiang Medical University, No. 137, South Liyushan Road, Xinjiang 830054, P. R. China

2 Department of Pathology, First Affiliated Hospital of Xinjiang Medical University, No. 137, South Liyushan Road, Xinjiang 830054, P. R. China

For all author emails, please log on.

Diagnostic Pathology 2014, 9:20  doi:10.1186/1746-1596-9-20

Published: 23 January 2014

Abstract

Purpose

This study is to investigate the estrogen receptor β (ERβ) expression in molecular subtypes of breast cancer and clinic significance of ERβ expression.

Method

The ERβ expression was detected in 730 cases of breast cancer tissue specimens by immunohistochemistry. Twenty-one patients were censored during 2–10 years follow-up. The difference in ERβ expression was analyzed by Pearson Chi-square Test. Its correlation with estrogen receptor α (ERα), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her-2) was analyzed by Spearman rank correlation. The accumulative tumor-free survival rate was calculated by Kaplan-Meier method and difference in survival rate was analyzed by Log-rank test. Cox regression was used for multi-factor analysis.

Result

The ERβ expression was significantly different among the molecular subtypes of breast cancer (P < 0.05). The ERβ expression in breast cancer was positively correlated with Her-2 (P < 0.05) while it had no correlation with ERα and Her-2. The expression of ERα was negatively correlated with Her-2 (P < 0.01) whereas positively correlated with PR (P < 0.01). The expression of PR was negatively correlated with Her-2 (P < 0.05). The tumor-free survival rate in patients with positive ERβ expression was significantly lower than that in patients with negative ERβ expression.

Conclusion

Positive ERβ expression is a poor prognostic factor of breast cancer.

Virtual slides

The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1084557586106833 webcite

Keywords:
Breast cancer; ERβ; Molecular subtypes